Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
Identifieur interne : 001300 ( Main/Corpus ); précédent : 001299; suivant : 001301Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
Auteurs : Arielle Mendel ; Sasha Bernatsky ; Anca Askanase ; Sang-Cheol Bae ; Ann Elaine Clarke ; Nathalie Costedoat-Chalumeau ; Dafna D. Gladman ; Caroline Gordon ; John Hanly ; S Ren Jacobsen ; Ken Kalunian ; Anselm Mak ; Marta Mosca ; Bernardo A. Pons-Estel ; Guillermo Ruiz-Irastorza ; Murray Urowitz ; Évelyne VinetSource :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2021.
English descriptors
- KwdEn :
- Antirheumatic Agents (supply & distribution), Antirheumatic Agents (therapeutic use), COVID-19 (drug therapy), Health Services Accessibility (MeSH), Humans (MeSH), Hydroxychloroquine (supply & distribution), Hydroxychloroquine (therapeutic use), Lupus Erythematosus, Systemic (drug therapy), SARS-CoV-2 (MeSH), Surveys and Questionnaires (MeSH).
- MESH :
- chemical , supply & distribution : Antirheumatic Agents, Hydroxychloroquine.
- chemical , therapeutic use : Antirheumatic Agents, Hydroxychloroquine.
- drug therapy : COVID-19, Lupus Erythematosus, Systemic.
- Health Services Accessibility, Humans, SARS-CoV-2, Surveys and Questionnaires.
DOI: 10.1136/annrheumdis-2020-218164
PubMed: 32586918
Links to Exploration step
pubmed:32586918Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.</title><author><name sortKey="Mendel, Arielle" sort="Mendel, Arielle" uniqKey="Mendel A" first="Arielle" last="Mendel">Arielle Mendel</name><affiliation><nlm:affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada arielle.mendel@mail.mcgill.ca.</nlm:affiliation></affiliation></author><author><name sortKey="Bernatsky, Sasha" sort="Bernatsky, Sasha" uniqKey="Bernatsky S" first="Sasha" last="Bernatsky">Sasha Bernatsky</name><affiliation><nlm:affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Askanase, Anca" sort="Askanase, Anca" uniqKey="Askanase A" first="Anca" last="Askanase">Anca Askanase</name><affiliation><nlm:affiliation>Division of Rheumatology, Columbia University Irving Medical Center, New York, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Bae, Sang Cheol" sort="Bae, Sang Cheol" uniqKey="Bae S" first="Sang-Cheol" last="Bae">Sang-Cheol Bae</name><affiliation><nlm:affiliation>Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seongdong-gu, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Clarke, Ann Elaine" sort="Clarke, Ann Elaine" uniqKey="Clarke A" first="Ann Elaine" last="Clarke">Ann Elaine Clarke</name><affiliation><nlm:affiliation>Division of Rheumatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Costedoat Chalumeau, Nathalie" sort="Costedoat Chalumeau, Nathalie" uniqKey="Costedoat Chalumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name><affiliation><nlm:affiliation>Centre de Référence Maladies Auto-immunes et Systémiques Rares, Service de Médecine Interne, Hôpital Cochin, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Gladman, Dafna D" sort="Gladman, Dafna D" uniqKey="Gladman D" first="Dafna D" last="Gladman">Dafna D. Gladman</name><affiliation><nlm:affiliation>Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Gordon, Caroline" sort="Gordon, Caroline" uniqKey="Gordon C" first="Caroline" last="Gordon">Caroline Gordon</name><affiliation><nlm:affiliation>Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Hanly, John" sort="Hanly, John" uniqKey="Hanly J" first="John" last="Hanly">John Hanly</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Jacobsen, S Ren" sort="Jacobsen, S Ren" uniqKey="Jacobsen S" first="S Ren" last="Jacobsen">S Ren Jacobsen</name><affiliation><nlm:affiliation>Copenhagen Lupus and Vasculitis Clinic, Section 4242, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation></affiliation></author><author><name sortKey="Kalunian, Ken" sort="Kalunian, Ken" uniqKey="Kalunian K" first="Ken" last="Kalunian">Ken Kalunian</name><affiliation><nlm:affiliation>Division of Rheumatology, University of California San Diego School of Medicine, La Jolla, California, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mak, Anselm" sort="Mak, Anselm" uniqKey="Mak A" first="Anselm" last="Mak">Anselm Mak</name><affiliation><nlm:affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</nlm:affiliation></affiliation></author><author><name sortKey="Mosca, Marta" sort="Mosca, Marta" uniqKey="Mosca M" first="Marta" last="Mosca">Marta Mosca</name><affiliation><nlm:affiliation>Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pons Estel, Bernardo A" sort="Pons Estel, Bernardo A" uniqKey="Pons Estel B" first="Bernardo A" last="Pons-Estel">Bernardo A. Pons-Estel</name><affiliation><nlm:affiliation>Regional Center for Autoimmune and Rheumatic Diseases of Rosario, Sanatorio Parque, Rosario, Argentina.</nlm:affiliation></affiliation></author><author><name sortKey="Ruiz Irastorza, Guillermo" sort="Ruiz Irastorza, Guillermo" uniqKey="Ruiz Irastorza G" first="Guillermo" last="Ruiz-Irastorza">Guillermo Ruiz-Irastorza</name><affiliation><nlm:affiliation>Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Urowitz, Murray" sort="Urowitz, Murray" uniqKey="Urowitz M" first="Murray" last="Urowitz">Murray Urowitz</name><affiliation><nlm:affiliation>Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Vinet, Evelyne" sort="Vinet, Evelyne" uniqKey="Vinet E" first="Évelyne" last="Vinet">Évelyne Vinet</name><affiliation><nlm:affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:32586918</idno><idno type="pmid">32586918</idno><idno type="doi">10.1136/annrheumdis-2020-218164</idno><idno type="wicri:Area/Main/Corpus">001300</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001300</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.</title><author><name sortKey="Mendel, Arielle" sort="Mendel, Arielle" uniqKey="Mendel A" first="Arielle" last="Mendel">Arielle Mendel</name><affiliation><nlm:affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada arielle.mendel@mail.mcgill.ca.</nlm:affiliation></affiliation></author><author><name sortKey="Bernatsky, Sasha" sort="Bernatsky, Sasha" uniqKey="Bernatsky S" first="Sasha" last="Bernatsky">Sasha Bernatsky</name><affiliation><nlm:affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Askanase, Anca" sort="Askanase, Anca" uniqKey="Askanase A" first="Anca" last="Askanase">Anca Askanase</name><affiliation><nlm:affiliation>Division of Rheumatology, Columbia University Irving Medical Center, New York, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Bae, Sang Cheol" sort="Bae, Sang Cheol" uniqKey="Bae S" first="Sang-Cheol" last="Bae">Sang-Cheol Bae</name><affiliation><nlm:affiliation>Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seongdong-gu, Republic of Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Clarke, Ann Elaine" sort="Clarke, Ann Elaine" uniqKey="Clarke A" first="Ann Elaine" last="Clarke">Ann Elaine Clarke</name><affiliation><nlm:affiliation>Division of Rheumatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Costedoat Chalumeau, Nathalie" sort="Costedoat Chalumeau, Nathalie" uniqKey="Costedoat Chalumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name><affiliation><nlm:affiliation>Centre de Référence Maladies Auto-immunes et Systémiques Rares, Service de Médecine Interne, Hôpital Cochin, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Gladman, Dafna D" sort="Gladman, Dafna D" uniqKey="Gladman D" first="Dafna D" last="Gladman">Dafna D. Gladman</name><affiliation><nlm:affiliation>Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Gordon, Caroline" sort="Gordon, Caroline" uniqKey="Gordon C" first="Caroline" last="Gordon">Caroline Gordon</name><affiliation><nlm:affiliation>Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Hanly, John" sort="Hanly, John" uniqKey="Hanly J" first="John" last="Hanly">John Hanly</name><affiliation><nlm:affiliation>Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Jacobsen, S Ren" sort="Jacobsen, S Ren" uniqKey="Jacobsen S" first="S Ren" last="Jacobsen">S Ren Jacobsen</name><affiliation><nlm:affiliation>Copenhagen Lupus and Vasculitis Clinic, Section 4242, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation></affiliation></author><author><name sortKey="Kalunian, Ken" sort="Kalunian, Ken" uniqKey="Kalunian K" first="Ken" last="Kalunian">Ken Kalunian</name><affiliation><nlm:affiliation>Division of Rheumatology, University of California San Diego School of Medicine, La Jolla, California, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mak, Anselm" sort="Mak, Anselm" uniqKey="Mak A" first="Anselm" last="Mak">Anselm Mak</name><affiliation><nlm:affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</nlm:affiliation></affiliation></author><author><name sortKey="Mosca, Marta" sort="Mosca, Marta" uniqKey="Mosca M" first="Marta" last="Mosca">Marta Mosca</name><affiliation><nlm:affiliation>Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pons Estel, Bernardo A" sort="Pons Estel, Bernardo A" uniqKey="Pons Estel B" first="Bernardo A" last="Pons-Estel">Bernardo A. Pons-Estel</name><affiliation><nlm:affiliation>Regional Center for Autoimmune and Rheumatic Diseases of Rosario, Sanatorio Parque, Rosario, Argentina.</nlm:affiliation></affiliation></author><author><name sortKey="Ruiz Irastorza, Guillermo" sort="Ruiz Irastorza, Guillermo" uniqKey="Ruiz Irastorza G" first="Guillermo" last="Ruiz-Irastorza">Guillermo Ruiz-Irastorza</name><affiliation><nlm:affiliation>Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Urowitz, Murray" sort="Urowitz, Murray" uniqKey="Urowitz M" first="Murray" last="Urowitz">Murray Urowitz</name><affiliation><nlm:affiliation>Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Vinet, Evelyne" sort="Vinet, Evelyne" uniqKey="Vinet E" first="Évelyne" last="Vinet">Évelyne Vinet</name><affiliation><nlm:affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Annals of the rheumatic diseases</title><idno type="eISSN">1468-2060</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antirheumatic Agents (supply & distribution)</term><term>Antirheumatic Agents (therapeutic use)</term><term>COVID-19 (drug therapy)</term><term>Health Services Accessibility (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (supply & distribution)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Lupus Erythematosus, Systemic (drug therapy)</term><term>SARS-CoV-2 (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Antirheumatic Agents</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term><term>Lupus Erythematosus, Systemic</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Services Accessibility</term><term>Humans</term><term>SARS-CoV-2</term><term>Surveys and Questionnaires</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32586918</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>02</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.</ArticleTitle><Pagination><MedlinePgn>1-2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-218164</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendel</LastName><ForeName>Arielle</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9732-616X</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada arielle.mendel@mail.mcgill.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernatsky</LastName><ForeName>Sasha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9515-2802</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Askanase</LastName><ForeName>Anca</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-4658-1093</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seongdong-gu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Ann Elaine</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costedoat-Chalumeau</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1555-9021</Identifier><AffiliationInfo><Affiliation>Centre de Référence Maladies Auto-immunes et Systémiques Rares, Service de Médecine Interne, Hôpital Cochin, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gladman</LastName><ForeName>Dafna D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0002-9074-0592</Identifier><AffiliationInfo><Affiliation>Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanly</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Søren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Copenhagen Lupus and Vasculitis Clinic, Section 4242, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalunian</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, University of California San Diego School of Medicine, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mak</LastName><ForeName>Anselm</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4688-7829</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosca</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pons-Estel</LastName><ForeName>Bernardo A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Regional Center for Autoimmune and Rheumatic Diseases of Rosario, Sanatorio Parque, Rosario, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Irastorza</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7788-1043</Identifier><AffiliationInfo><Affiliation>Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urowitz</LastName><ForeName>Murray</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7506-9166</Identifier><AffiliationInfo><Affiliation>Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinet</LastName><ForeName>Évelyne</ForeName><Initials>É</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">epidemiology</Keyword><Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword><Keyword MajorTopicYN="Y">lupus erythematosus</Keyword><Keyword MajorTopicYN="Y">systemic</Keyword></KeywordList><CoiStatement>Competing interests: AEC reports consulting fees (less than $10 000) from Bristol Myers Squibb, Exagen Diagnostics and AstraZenca, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32586918</ArticleId><ArticleId IdType="pii">annrheumdis-2020-218164</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-218164</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001300 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001300 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32586918
|texte= Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32586918" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |